StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nutra Pharma's revenue for the twelve months ending Jun 30, 2026 was $160.82K, down 49.0% year over year. For fiscal 2025 it was $257.61K, up 4.6% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $1.43M in fiscal 2010.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$257.61K+4.6%
FY2024Dec 31, 2024$246.31K+19.8%
FY2023Dec 31, 2023$205.56K+41.0%
FY2022Dec 31, 2022$145.80K+49.2%
FY2021Dec 31, 2021$97.74K+88.3%
FY2020Dec 31, 2020$51.90K-50.3%
FY2019Dec 31, 2019$104.39K-20.1%
FY2018Dec 31, 2018$130.60K+7.9%
FY2017Dec 31, 2017$120.98K-28.1%
FY2016Dec 31, 2016$168.36K-42.2%
FY2015Dec 31, 2015$291.30K-51.0%
FY2014Dec 31, 2014$594.51K+467.1%
FY2013Dec 31, 2013$104.84K-48.4%
FY2012Dec 31, 2012$203.29K+27.4%
FY2011Dec 31, 2011$159.60K-88.9%
FY2010Dec 31, 2010$1.43M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$34.46K-59.2%
Q1 FY2026Mar 31, 2026$27.25K-63.2%
Q4 FY2025Dec 31, 2025$28.86K-64.7%
Q3 FY2025Sep 30, 2025$70.24K-6.3%
Q2 FY2025Jun 30, 2025$84.53K+63.5%
Q1 FY2025Mar 31, 2025$73.97K+96.1%
Q4 FY2024Dec 31, 2024$81.87K+74.1%
Q3 FY2024Sep 30, 2024$74.99K+45.3%
Q2 FY2024Jun 30, 2024$51.71K-1.3%
Q1 FY2024Mar 31, 2024$37.73K-30.8%
Q4 FY2023Dec 31, 2023$47.03K-40.5%
Q3 FY2023Sep 30, 2023$51.61K+109.6%
Q2 FY2023Jun 30, 2023$52.40K+84.3%
Q1 FY2023Mar 31, 2023$54.52K+296.3%
Q4 FY2022Dec 31, 2022$78.99K+203.9%
Q3 FY2022Sep 30, 2022$24.62K+27.8%
Q2 FY2022Jun 30, 2022$28.43K-6.7%
Q1 FY2022Mar 31, 2022$13.76K-37.5%
Q4 FY2021Dec 31, 2021$25.99K+71.3%
Q3 FY2021Sep 30, 2021$19.27K+44.1%
Q2 FY2021Jun 30, 2021$30.46K+388.1%
Q1 FY2021Mar 31, 2021$22.02K+28.7%
Q4 FY2020Dec 31, 2020$15.17K+39.2%
Q3 FY2020Sep 30, 2020$13.37K-68.1%
Q2 FY2020Jun 30, 2020$6.24K-38.9%
Q1 FY2020Mar 31, 2020$17.12K-58.6%
Q4 FY2019Dec 31, 2019$10.89K-58.5%
Q3 FY2019Sep 30, 2019$41.96K-4.6%
Q2 FY2019Jun 30, 2019$10.22K-65.2%
Q1 FY2019Mar 31, 2019$41.32K+27.2%
Q4 FY2018Dec 31, 2018$26.27K-19.8%
Q3 FY2018Sep 30, 2018$43.97K+158.9%
Q2 FY2018Jun 30, 2018$29.38K-4.2%
Q1 FY2018Mar 31, 2018$32.48K-13.1%
Q4 FY2017Dec 31, 2017$32.77K–
Q1 FY2017Mar 31, 2017$16.98K–
Q2 FY2016Jun 30, 2016$30.68K–
Q1 FY2016Mar 31, 2016$37.39K–

More Nutra Pharma figures

See a number that looks wrong?